First UK real-world study shows promise for sacituzumab govitecan in metastatic breast cancer Post author: Post published:April 26, 2024 Post category:uncategorized The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer. You Might Also Like AI’s potential to improve healthcare access could be offset by exploitation October 8, 2024 Children and adolescents experience unique long COVID symptoms August 26, 2024 Researchers enhance longevity of neural implants with protective coating January 7, 2025